- Home
- MRVI vs MUA Comparison
MRVI vs MUA Comparison
Compare MRVI & MUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- MUA
- Stock Information
- Founded
- MRVI 2014
- MUA 1993
- Country
- MRVI United States
- MUA United States
- Employees
- MRVI N/A
- MUA N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- MUA Investment Bankers/Brokers/Service
- Sector
- MRVI Health Care
- MUA Finance
- Exchange
- MRVI Nasdaq
- MUA Nasdaq
- Market Cap
- MRVI 376.2M
- MUA 427.1M
- IPO Year
- MRVI 2020
- MUA N/A
- Fundamental
- Price
- MRVI $3.34
- MUA $10.98
- Analyst Decision
- MRVI Hold
- MUA
- Analyst Count
- MRVI 9
- MUA 0
- Target Price
- MRVI $4.54
- MUA N/A
- AVG Volume (30 Days)
- MRVI 1.4M
- MUA 92.6K
- Earning Date
- MRVI 11-06-2025
- MUA 01-01-0001
- Dividend Yield
- MRVI N/A
- MUA 4.84%
- EPS Growth
- MRVI N/A
- MUA N/A
- EPS
- MRVI N/A
- MUA N/A
- Revenue
- MRVI $219,830,000.00
- MUA N/A
- Revenue This Year
- MRVI N/A
- MUA N/A
- Revenue Next Year
- MRVI $7.23
- MUA N/A
- P/E Ratio
- MRVI N/A
- MUA N/A
- Revenue Growth
- MRVI N/A
- MUA N/A
- 52 Week Low
- MRVI $1.67
- MUA $8.61
- 52 Week High
- MRVI $8.54
- MUA $11.43
- Technical
- Relative Strength Index (RSI)
- MRVI 69.44
- MUA 47.26
- Support Level
- MRVI $2.94
- MUA $10.87
- Resistance Level
- MRVI $3.30
- MUA $11.34
- Average True Range (ATR)
- MRVI 0.20
- MUA 0.16
- MACD
- MRVI 0.04
- MUA -0.07
- Stochastic Oscillator
- MRVI 91.98
- MUA 11.48
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About MUA Blackrock MuniAssets Fund Inc
Blackrock Muniassets Fund Inc is a closed-end fund. Its objective is to provide high current income exempt from U.S. federal income taxes by investing in a portfolio of medium- to lower-grade or unrated municipal obligations. The Fund invests more of its total assets in municipal bonds.